An Integrated Efficacy and Safety Analysis of Single-Dose Secnidazole 2 g in the Treatment of Bacterial Vaginosis

Bacterial vaginosis (BV) is the most common gynecologic infection in women aged 14 to 49 years. Currently recommended treatments require extended dosing and are thus associated with poor adherence. A single-dose oral granule formulation of secnidazole 2 g (SOLOSEC™ [secnidazole], Symbiomix Therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Pentikis, Helen, Adetoro, Nikki, Tipping, Diane, Levy, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077929/
https://www.ncbi.nlm.nih.gov/pubmed/32046418
http://dx.doi.org/10.1007/s43032-019-00048-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077929/
https://www.ncbi.nlm.nih.gov/pubmed/32046418
http://dx.doi.org/10.1007/s43032-019-00048-x

Ejemplares similares